Clinical Trial Update: RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial [NA]

View source ↗

Summary

The RELIVE trial, sponsored by BioVentrix, is currently recruiting to evaluate a less invasive ventricular enhancement approach in patients with left ventricula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: BioVentrix | Conditions: Left Ventricle Remodeling, Left Ventricle Dilated | NA | Status: RECRUITING